These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35335892)

  • 1. Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People.
    Bracken L; Habashy R; McDonough E; Wilson F; Shakeshaft J; Ohia U; Garcia-Sorribes T; Isreb A; Alhnan MA; Peak M
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)).
    Bracken L; McDonough E; Ashleigh S; Wilson F; Shakeshaft J; Ohia U; Mistry P; Jones H; Kanji N; Liu F; Peak M
    BMJ Open; 2020 Oct; 10(10):e036508. PubMed ID: 33039988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the geometry of 3D printed solid oral dosage forms on their swallowability.
    Bogdahn M; Torner J; Krause J; Grimm M; Weitschies W
    Eur J Pharm Biopharm; 2021 Oct; 167():65-72. PubMed ID: 34298113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I Spy with My Little Eye: A Paediatric Visual Preferences Survey of 3D Printed Tablets.
    Januskaite P; Xu X; Ranmal SR; Gaisford S; Basit AW; Tuleu C; Goyanes A
    Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33212847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient acceptability of 3D printed medicines.
    Goyanes A; Scarpa M; Kamlow M; Gaisford S; Basit AW; Orlu M
    Int J Pharm; 2017 Sep; 530(1-2):71-78. PubMed ID: 28750894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review.
    Hauber B; Hand MV; Hancock BC; Zarrella J; Harding L; Ogden-Barker M; Antipas AS; Watt SJ
    Patient Prefer Adherence; 2024; 18():1281-1297. PubMed ID: 38919378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-Analytical Framework to Assess the In Vitro Swallowability of Solid Oral Dosage Forms Targeting Patient Acceptability and Adherence.
    Ershad AL; Rajabi-Siahboomi A; Missaghi S; Kirby D; Mohammed AR
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33808875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
    Münch J; Sessler I; Bosse HM; Wargenau M; Dreesen JD; Loforese G; Webb NJA; Sivasubramanian R; Reidemeister S; Lustenberger P; Klingmann V
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensory aspects of acceptability of bitter-flavoured 7.5 mm film-coated tablets in adults, preschool and school children.
    Hofmanová JK; Mason J; Batchelor HK
    Int J Pharm; 2020 Jul; 585():119511. PubMed ID: 32522503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Solid Oral Dosage Form Characteristics on Swallowability, Visual Perception, and Handling in Older Adults.
    Hummler H; Page S; Stillhart C; Meilicke L; Grimm M; Mannaa M; Gollasch M; Weitschies W
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability, Swallowability, Palatability, and Safety of Multiple Film-Coated Mini-Tablets in Children Aged ≥2-<7 Years: Results of an Open-Label Randomised Study.
    Münch J; Kloft C; Farhan M; Fishman V; Leng S; Bosse HM; Klingmann V
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can filaments be stored as a shelf-item for on-demand manufacturing of oral 3D printed tablets? An initial stability assessment.
    Okwuosa TC; Sadia M; Isreb A; Habashy R; Peak M; Alhnan MA
    Int J Pharm; 2021 May; 600():120442. PubMed ID: 33675925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Tablet Size and Shape on the Swallowability in Older Adults.
    Hummler H; Stillhart C; Meilicke L; Grimm M; Krause E; Mannaa M; Gollasch M; Weitschies W; Page S
    Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.
    Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F
    Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
    Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
    Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions, preferences and acceptability of patient designed 3D printed medicine by polypharmacy patients: a pilot study.
    Fastø MM; Genina N; Kaae S; Kälvemark Sporrong S
    Int J Clin Pharm; 2019 Oct; 41(5):1290-1298. PubMed ID: 31444687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
    Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
    Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.